Skip to main content
CARE
NASDAQ Finance

Carter Bankshares Sells $209M Non-Performing Loans for $289M Cash, Drastically Improving Asset Quality

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
9
Price
$20.345
Mkt Cap
$450.936M
52W Low
$13.605
52W High
$22.51
Market data snapshot near publication time

summarizeSummary

Carter Bankshares completed the sale of $209.48 million in non-performing loans for $289.48 million in cash, drastically reducing its non-performing loan ratio and boosting tangible book value.


check_boxKey Events

  • Major Non-Performing Loan Sale Completed

    The company completed the sale of all loans related to James C. Justice, II entities, which were previously nonperforming and on nonaccrual status. The transaction generated $289.48 million in cash.

  • Significant Improvement in Asset Quality

    The sale drastically reduced non-performing loans from $243.98 million (6.29% of total loans) to a pro forma $29.96 million (0.82% of total loans), significantly cleaning up the balance sheet.

  • Tangible Book Value Boost

    The transaction is estimated to favorably impact the company's tangible book value per common share by approximately $3.49.

  • Gain on Loan Sale

    The company received $289.48 million in cash for loans with an outstanding principal of $209.48 million and a specific reserve of $18.04 million, indicating a substantial recovery and gain.


auto_awesomeAnalysis

This filing reports a highly significant transaction for Carter Bankshares, addressing a major challenge previously highlighted in its 10-K. The sale of $209.48 million in non-performing loans (NPLs) for $289.48 million in cash not only provides a substantial cash infusion but also fundamentally de-risks the bank's balance sheet. The reduction of NPLs from 6.29% to a pro forma 0.82% of total loans is a dramatic improvement in asset quality, which should positively impact investor confidence and future profitability. The estimated $3.49 per share increase in tangible book value further underscores the positive financial impact of this strategic move.

At the time of this filing, CARE was trading at $20.35 on NASDAQ in the Finance sector, with a market capitalization of approximately $450.9M. The 52-week trading range was $13.61 to $22.51. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CARE - Latest Insights

CARE
Apr 23, 2026, 8:16 AM EDT
Filing Type: 8-K
Importance Score:
8
CARE
Apr 23, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
9
CARE
Mar 26, 2026, 2:15 PM EDT
Filing Type: 8-K
Importance Score:
9
CARE
Mar 05, 2026, 12:53 PM EST
Filing Type: 10-K
Importance Score:
8
CARE
Feb 02, 2026, 8:16 AM EST
Filing Type: 8-K
Importance Score:
8
CARE
Jan 29, 2026, 8:16 AM EST
Filing Type: 8-K
Importance Score:
8